Bruce G Haffty, MD

Chair, Radiation Oncology, RWJMS The Cancer Institute of New Jersey (CINJ) 195 Little Albany Street, Room 2006 New Brunswick, NJ 08901 hafftybg@umdnj.edu

Clinical Specialty: Breast Cancer

Degree

• MD from Yale University

Grants

• The Glutmatergic Pathways in Melanoma (NJCCR)
• Impact of a common MDM2 SNP on the sensitivity to breast cancer treatment (DOD)
• Significance of SNP309 in early onset breast cancer (CINJ Breast Cancer Research Grant )
• Evaluation of the p53 binding protein 53BP1 in the local-regional management of breast cancer (Breast Cancer Research Foundation)

Positions

• Program Director (09/2005 - 06/2009)
  Department of Radiation Oncology Residency Training Program
  UMDNJ-Robert Wood Johnson Medical School
• Associate Director (09/2005 - Present)
  CINJ
• Professor and Chairman (09/2005 - Present)
  Department of Radiation Oncolgy
  UMDNJ-Robert Wood Johnson Medical School

Honors

• National Science Foundation Student Originated Studies Award
  National Science Foundation (1975)
• National Institute Health Summer Fellowship
  National Institutes of Health (1983)
• Merck Award
  Yale Medical School (1984)
• Leadership in Patient Care Award
  CINJ (2008)

Society

• Residency Review Committee Radiation Oncology, ACGME (2007 - Present)
• American Radium Society (2008 - 2009)
• American Board of Radiology (2008 - 2010)
• Radiological Society of North America (2005 - Present)
• Society of Chairman of Academic Radiation Oncology Programs (2006 - Present)

Publications

• Haffty BG, Yang Q, Moran MS, Tan AR, Reiss M. Estrogen-Dependent Prognostic Significance of Cyclooxygenase-2 Expression in Early-Stage Invasive Breast Cancers Treated with Breast-Conserving Surgery and Radiation Int J Radiat Oncol Biol Phys. 2008;
• Haffty BG, Vicini FA, Beitsch P, Quiet C, Keleher A, Garcia D, Snider H, Gittleman M, Zannis V, Kuerer H, Whitacre E, Whitworth P, Fine R, Keisch M. Timing of Chemotherapy After MammoSite Radiation Therapy System Breast Brachytherapy: Analysis of the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial Int J Radiat Oncol Biol Phys. 2008;
• Goyal S, Yue NJ, Millevoi R, Kagen E, Haffty B, Narra V. Improvement in dose homogeneity with electronic tissue compensation over IMRT and conventional RT in whole brain radiotherapy Radiother Oncol. 2008;
• Moran MS, Yang Q, Harris LN, Jones B, Tuck DP, Haffty BG Long-term outcomes and clinicopathologic differences of African-American versus white patients treated with breast conservation therapy for early-stage breast cancer Cancer. 2008;
• Parikh RR, Housman D, Yang Q, Toppmeyer D, Wilson LD, Haffty BG. Prognostic value of triple-negative phenotype at the time of locally recurrent, conservatively treated breast cancer Int J Radiat Oncol Biol Phys. 2008;
• Psyrri A, Egleston B, Weinberger P, Yu Z, Kowalski D, Sasaki C, Haffty B, Rimm D, Burtness B. Correlates and determinants of nuclear epidermal growth factor receptor content in an oropharyngeal cancer tissue microarray Cancer Epidemiol Biomarkers Prev. 2008;
• Tripuraneni P, Watson RL, Ang KK, Harrison L, Eifel P, Zietman A, Haffty B, Thevenot LI, Willett CG, Schomberg PJ, Pickles T, Halberg FE, Devlin PM Intersociety Radiation Oncology Summit-SCOPE II. Int J Radiat Oncol Biol Phys. 2008;
• Yue NJ, Kim S, Lewis BE, Jabbour S, Narra V, Goyal S, Haffty BG Optimization of couch translational corrections to compensate for rotational and deformable target deviations in image guided radiotherapy Med Phys.. 2008;